-
-
-
-
-
-
-
Merck (MRK) PT Raised to $142 at BMO Capital
-
-
-
-
-
-
-
Johnson & Johnson to stay out of obesity drugs, focus on cancer, CEO says
-
-
-
-
-
-
-
Merck (MRK) Declares $0.85 Quarterly Dividend; 2.8% Yield
-
-
-
-
-
-
-
Citi Reinstates Merck (MRK) at Neutral
-
-
-
-
-
-
-
UBS Reiterates Buy Rating on Merck (MRK)
-
-
-
-
-
-
-
Merck (MRK) Reiterated at Neutral by Cantor Fitzgerald As '26 Catalysts Already Credited
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Merck (MRK)
-
432,110 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

